Embryonal Rhabdomyosarcoma of the Uterine Cervix: A Clinicopathologic Study of 94 Cases Emphasizing Issues in Differential Diagnosis Staging, and Prognostic Factors.
Journal
The American journal of surgical pathology
ISSN: 1532-0979
Titre abrégé: Am J Surg Pathol
Pays: United States
ID NLM: 7707904
Informations de publication
Date de publication:
01 11 2022
01 11 2022
Historique:
pubmed:
9
8
2022
medline:
19
10
2022
entrez:
8
8
2022
Statut:
ppublish
Résumé
Embryonal rhabdomyosarcoma of the uterine cervix (cERMS) is rare and frequently associated with DICER1 mutations. We report 94 tumors that arose in patients aged 7 to 59 (median=23) years and presented with vaginal bleeding (52), protruding vaginal mass (17), cervical polyp (8), or expelled tumor fragments per vagina (5). Nine had DICER1 syndrome, 8 of whom had other syndromic manifestations including ovarian Sertoli-Leydig cell tumor (7), multinodular goiter (3), pleuropulmonary blastoma (2), pineoblastoma (1), and osteosarcoma (1). Syndromic patients were younger than nonsyndromic patients (16 vs. 24 y). Tumor size ranged from 2 to 24 (median=4.5) cm. Ninety-two tumors were polypoid, most being grape-like (77 of 92). They were characterized by aggregates of primitive cells, almost always exhibiting a cambium layer, within a variably myxoedematous stroma and were hypocellular (63), moderately cellular (22), or hypercellular (9). Entrapped glands, typically scant, were present in 84 tumors. Primitive hyperchromatic ovoid to spindled cells with minimal cytoplasm predominated but differentiated rhabdomyoblasts with abundant eosinophilic cytoplasm (having cross-striations in 30) were seen in 83 tumors; they were often sparse but predominated in three. Nine tumors showed areas of intersecting fascicles and 4 zones with densely cellular (solid) growth. Cartilage was present in 38. Anaplasia was seen in 15 tumors, as was necrosis. Mitotic activity ranged from 1 to 58/10 high-power fields (median=8). The varied microscopic features resulted in a spectrum of differential diagnostic considerations, mainly typical and cellular forms of fibroepithelial polyps, Mullerian adenosarcoma, and other sarcomas. Follow-up was available for 79 patients ranging from 6 to 492 (median=90) months. Treatment information was available in 62 and included polypectomy in 6 patients (2 also received chemotherapy), limited resection in 26 (14 also received chemotherapy), hysterectomy in 29 (15 with adjuvant chemotherapy), and biopsies only in 1 (with chemotherapy). Staging was possible in 56 tumors; according to the "uterine sarcoma" system (tumor size and extent) they were: stage I (10/56; could not be further subclassified as size not available), IA (22/56), IB (18/56), IIA (2/56), IIB 3/56), IIIC (1/56). According to the "adenosarcoma" system (depth of invasion and extent) they were: stage IA (26/56), IB (14/56), IC (10/56), IIA (2/56), IIB (3/56), IIIC (1/56). Eight patients had local recurrence following incomplete excision (10%). Eleven of 79 patients had extrauterine recurrences (14%) and 9 died of disease (11%). Older age was associated with extrauterine recurrence (median 44 vs. 22; P =0.002) and decreased disease-specific survival (median 44 vs. 22; P =0.02). For patients with tumors initially confined to the cervix, the adenosarcoma staging system was superior to the uterine sarcoma staging system for predicting survival ( P =0.02). Three patients with DICER1 syndrome who underwent fertility-preserving surgery developed a second primary cERMS 7, 7, and 12 years after their primary tumor. All 9 patients with DICER1 syndrome had tumors confined to the cervix and none died of disease. This study highlights the intriguing clinical aspects of cERMS including its long-known tendency to occur in the young but also more recently appreciated association with DICER1 syndrome. Establishing the diagnosis may still be difficult because of the hazard of sampling a neoplasm which in areas may appear remarkably bland and also because of its potential confusion with other neoplasms. This study indicates that this tumor has a good prognosis at this site and in selected cases a conservative surgical approach is a realistic consideration.
Identifiants
pubmed: 35941719
doi: 10.1097/PAS.0000000000001933
pii: 00000478-202211000-00003
doi:
Substances chimiques
DICER1 protein, human
EC 3.1.26.3
Ribonuclease III
EC 3.1.26.3
DEAD-box RNA Helicases
EC 3.6.4.13
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1477-1489Informations de copyright
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
Conflicts of Interest and Source of Funding: The authors have disclosed that they have no significant relationships with, or financial interest in, any commercial companies pertaining to this article.
Références
Sultan I, Qaddoumi I, Yaser S, et al. Comparing adult and pediatric rhabdomyosarcoma in the surveillance, epidemiology and end results program, 1973 to 2005: an analysis of 2,600 patients. J Clin Oncol. 2009;27:3391–3397.
Nasioudis D, Alevizakos M, Chapman-Davis E, et al. Rhabdomyosarcoma of the lower female genital tract: an analysis of 144 cases. Arch Gynecol Obstet. 2017;296:327–334.
Daya DA, Scully RE. Sarcoma botryoides of the uterine cervix in young women: a clinicopathological study of 13 cases. Gynecol Oncol. 1988;29:290–304.
Dehner LP, Jarzembowski JA, Hill DA. Embryonal rhabdomyosarcoma of the uterine cervix: a report of 14 cases and a discussion of its unusual clinicopathological associations. Mod Pathol. 2012;25:602–614.
Li RF, Gupta M, McCluggage WG, et al. Embryonal rhabdomyosarcoma (botryoid type) of the uterine corpus and cervix in adult women: a report of a case series and review of the literature. Am J Surg Pathol. 2013;37:344–355.
Ferguson SE, Gerald W, Barakat RR, et al. Clinicopathologic features of rhabdomyosarcoma of gynecologic origin in adults. Am J Surg Pathol. 2007;31:382–389.
Bennett JA, Ordulu Z, Young RH, et al. Embryonal rhabdomyosarcoma of the uterine corpus: a clinicopathological and molecular analysis of 21 cases highlighting a frequent association with DICER1 mutations. Mod Pathol. 2021;34:1750–1762.
de Kock L, Druker H, Weber E, et al. Ovarian embryonal rhabdomyo- sarcoma is a rare manifestation of the DICER1 syndrome. Hum Pathol. 2015;46:917–922.
McCluggage WG, Apellaniz-Ruiz M, Chong AL, et al. Embryonal rhabdomyosarcoma of the ovary and fallopian tube: rare neoplasms associated with germline and somatic DICER1 mutations. Am J Surg Pathol. 2020;44:738–747.
Kebudi R, Dural O, Bay S, et al. Childhood rhabdomyosarcoma of the female genital tract: association with pathologenic DICER1 variation, clinicopathological features, and outcomes. J Pediatr Adolesc Gynecol. 2021;34:449–453.
de Kock L, Yoon JY, Apellaniz-Ruiz M, et al. Significantly greater prevalence of DICER1 alterations in uterine embryonal rhabdomyosarcoma compared to adenosarcoma. Mod Pathol. 2020;33:1207–1219.
Doros L, Yang J, Dehner L, et al. DICER1 mutations in embryonal rhabdomyosarcomas from children with and without familial PPB-tumor predisposition syndrome. Pediatr Blood Cancer. 2012;59:558–560.
Hill DA, Ivanovich J, Priest JR, et al. DICER1 mutations in familial pleuropulmonary blastoma. Science (1979). 2009;325:965.
Bahubeshi A, Bal N, Rio Frio T, et al. Germline DICER1 mutations and familial cystic nephroma. J Med Genet. 2010;47:863–866.
Schultz KAP, Williams GM, Kamihara J, et al. DICER1 and associated conditions: identification of at-risk individuals and recommended surveillance strategies. Clin Cancer Res. 2018;24:2251–2261.
Schultz KAP, Pacheco MC, Yang J, et al. Ovarian sex cord-stromal tumors, pleuropulmonary blastoma, and DICER1 mutations: a report from the International Pleuropulmonary Blastoma Registry. Gynecol Oncol. 2011;122:246–250.
Kroll-Wheeler L, Heider A. Anaplastic sarcoma of the kidney with heterologous ganglioneuroblastic differentiation: another DICER1-associated tumor. Pediatr Dev Pathol. 2021;25:186–191.
Schultz KAP, Sterwart DR, Kamihara J, et al. Adam MP, Ardinger HH, Pagon RA. DICER1 tumor predisposition. GeneReviews. University of Washingtion, Seattle (WA). 2014.
Kommoss FKF, Stichel D, Mora J, et al. Clinicopathologic and molecular analysis of embryonal rhabdomyosarcoma of the genitourinary tract: evidence for a distinct DICER1-associated subgroup. Mod Pathol. 2021;34:1558–1569.
Kriseman ML, Wang WL, Sullinger J, et al. Rhabdomyosarcoma of the cervix in adult women and younger patients. Gynecol Oncol. 2012;126:1–6.
Buruiana FE, Gupta B, Singh K. Rhabdomyosarcoma of the cervix in teenagers - is fertility preservation an option? Gynecol Oncol Rep. 2020;34:100677.
Elebaie MAT, Elsayed Z. Is fertility-preservation safe for adult non-metastatic gynecologic rhabdomyosarcoma patients? Systematic review and pooled survival analysis of 137 patients. Arch Gynecol Oncol. 2018;297:559–572.
Bouchard-Fortier G, Kim RH, Allen L, et al. Fertility-sparing surgery for the management of young women with embryonal rhabdomyosarcoma of the cervix: a case series. Gynecol Oncol Rep. 2016;18:4–7.
Kirsch CH, Goodman M, Esiashvili N. Outcome of female pediatric patients diagnosed with genital tract rhabdomyosarcoma based on analysis of cases registered in SEER database between 1973 and 2006. Am J Clin Oncol. 2014;37:47–50.
Minard-Colin V, Walterhouse D, Bisogno G, et al. Localized vaginal/uterine rhabdomyosarcoma—results of a pooled analysis from four international cooperative groups. Pediatr Blood Cancer. 2018;65:e27096.
Cowan M, Suntum T, Olivas AD, et al. Second primary rhabdomyosarcoma of the uterine cervix presenting with synchronous ovarian Sertoli-Leydig cell tumor: an illustrative case of DICER1 syndrome. Gynecol Oncol Rep. 2018;25:94–97.
Golbang P, Khan A, Scurry J, et al. Cervical sarcoma botryoides and ovarian Sertoli-Leydig cell tumor. Gynecol Oncol. 1997;67:102–106.
Siegel DA, King J, Tai E, et al. Cancer incidence rates and trends among children and adolescents in the United States, 2001–2009. Pediatrics. 2014;134:e945–e955.
The WHO Classification of Tumours Editorial Board. WHO Classification of Tumours: Soft Tissue and Bone Tumours, 5th ed. Lyon, IARC Press. 2020.
Guersant MP. Polypes du vagin chez une petite fille de treize mois. Moniteur Hopitaux. 1854;2:187–189.
Spiegelberg O. Sarcoma colli uteri hydropicum papillare. Arch Gynaek. 1879;14:178.
Pfannenstiel J. Das traubige sarcom der cervix uteri. Virchows Arch. 1892;127:305–337.
Yoon JY, Apellaniz-Ruiz M, Chong AL, et al. The value of DICER1 mutation analysis in “subtle” diagnostically challenging embryonal rhabdomyosarcomas of the uterine cervix. Int J Gynecol Pathol. 2021;40:435–440.
Rudzinski ER, Teot LA, Anderson JR, et al. Dense pattern of embryonal rhabdomyosarcoma, a lesion easily confused with alveolar rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children’s Oncology Group. Am J Clin Pathol. 2013;140:82–90.
Pinto A, Kahn RM, Rosenberg AE, et al. Uterine rhabdomyosarcoma in adults. Hum Pathol. 2018;74:122–128.
Allende DS, Yang B. Primary ovarian rhabdomyosarcoma with heterologous elements: a case report. Int J Gynecol Pathol. 2008;27:402–406.
Nielsen GP, Oliva E, Young RH, et al. Primary ovarian rhabdomyosarcoma: a report of 13 cases. Int J Gynecol Pathol. 1998;17:113–119.
Warren M, Hiemenz MC, Schmidt R, et al. Expanding the spectrum of dicer1-associated sarcomas. Mod Pathol. 2020;33:164–174.
Al-Shedoukhy A, Qayyum A. Urinary bladder botryoid rhabdomyosarcoma with immature cartilage in a 24-year-old male patient: a case report. Saudi J Kidney Dis Transpl. 2003;14:522–525.
Paner GP, McKenney JK, Epstein JI, et al. Rhabdomyosarcoma of the urinary bladder in adults: predilection for alveolar morphology with anaplasia and significant morphologic overlap with small cell carcinoma. Am J Surg Pathol. 2008;32:1022–1028.
Peters SM, Kunkle T, Perrino MA, et al. Mandibular embryonal rhabdomyosarcoma with cartilaginous metaplasia: report of a case and review of literature. Oral Surg Oral Med Oral Pathol Oral Radiol. 2017;124:e288–e293.
de Kock L, Wu MK, Foulkes WD. Ten years of DICER1 mutations: provenance, distribution, and associated phenotypes. Hum Mutat. 2019;40:1939–1953.
Norris HJ, Taylor HB. Polyps of the vagina. A benign lesion resembling sarcoma botryoides. Cancer. 1966;19:227–232.
Nucci MR, Young RH, Fletcher CD. Cellular pseudosarcomatous fibroepithelial stromal polyps of the lower female genital tract: an underrecognized lesion often misdiagnosed as sarcoma. Am J Surg Pathol. 2000;24:231–240.
McCluggage WG, Longacre TA, Fisher C. Myogenin expression in vulvovaginal spindle cell lesions: analysis of a series of cases with an emphasis on diagnostic pitfalls. Histopathology. 2013;63:545–550.
Olson NJ, Fritchie KJ, Torres-Mora J, et al. MyoD1 expression in fibroepithelial stromal polyps. Hum Pathol. 2020;99:75–79.
Cakar B, Muslu U, Karaca B, et al. Alveolar rhabdomyosarcoma originating from the uterine cervix. Eur J Gynaecol Oncol. 2011;32:196–198.
Fivasi F, Botticelli L, Bettelli SR, et al. Alveolar rhabdomyosarcoma of the uterine cervix: a case report confirmed by FKHR break-apart rearrangement using a fluorescence in situ hybridization probe on paraffin-embedded tissues. Int J Gynecol Pathol. 2008;27:442–446.
Kodet R, Newton WA Jr, Hamoudi AB, et al. Orbital rhabdomyosarcomas and related tumors in childhood: relationship of morphology to prognosis—an Intergroup Rhabdomyosarcoma Study. Med Pediatr Oncol. 1997;29:51–60.
Teot LA, Schneider M, Thorner AR, et al. Clinical and mutational spectrum of highly differentiated, paired box 3:forkhead box protein o1 fusion-negative rhabdomyosarcoma: a report from the Children’s Oncology Group. Cancer. 2018;124:1973–1981.
Arndt CAS, Hammond S, Rodeberg D, et al. Significance of persistent mature rhabdomyoblasts in bladder/prostate rhabdomyosarcoma: results from IRS IV. J Pediatr Hematol Oncol. 2006;28:563–567.
Cavazzana AO, Schmidt D, Ninfo V, et al. Spindle cell rhabdomyosarcoma: a prognostically favorable variant of rhabdomyosarcoma. Am J Surg Pathol. 1992;16:229–235.
Agaram NP, LaQuaglia MP, Alaggio R, et al. MYOD1-mutant spindle cell and sclerosing rhabdomyosarcoma: an aggressive subtype irrespective of age. A reappraisal for molecular classification and risk stratification. Mod Pathol. 2019;32:27–36.
McCluggage WG, Lioe TF, McClelland HR, et al. Rhabdomyosarcoma of the uterus: report of two cases, including one of the spindle cell variant. Int J Gynecol Cancer. 2002;12:128–132.
Rubin BP, Hasserjian RP, Singer S, et al. Spindle cell rhabdomyosarcoma (so-called) in adults: report of two cases with emphasis on differential diagnosis. Am J Surg Pathol. 1998;22:459–464.
Watanabe K, Kusakabe T, Hoshi N, et al. h-Caldesmon in leiomyosarcoma and tumors with smooth muscle cell-like differentiation: its specific expression in the smooth muscle cell tumor. Hum Pathol. 1999;30:392–396.
Clement PB, Scully RE. Mullerian adenosarcoma of the uterus: a clinicopathologic analysis of 100 cases with a review of the literature. Hum Pathol. 1990;21:363–381.
Clement PB. Mullerian adenosarcomas of the uterus with sarcomatous overgrowth: a clinicopathological analysis of 10 cases. Am J Surg Pathol. 1989;13:28–38.
Soslow RA, Ali A, Oliva E. Mullerian adenosarcomas: an immunophenotypic analysis of 35 cases. Am J Surg Pathol. 2008;32:1013–1021.
Bean GR, Anderson J, Sangoi AR, et al. DICER1 mutations are frequent in müllerian adenosarcomas and are independent of rhabdomyosarcomatous differentiation. Mod Pathol. 2019;32:280–289.
Lautz TB, Martelli H, Fuchs J, et al. Local treatment of rhabdomyosarcoma of the female genital tract: Expert consensus from the Children’s Oncology Group, the European Soft-Tissue Sarcoma Group, and the Cooperative Weichteilsarkom Studiengruppe. Pediatr Blood Cancer. 2020:e28601.
Nigro MC, Nannini M, Rizzo A, et al. Current status on treatment of uterine adenosarcoma: updated literature review. Gynecol Pelvic Med. 2021;4:15.
Stolnicu S, Goyenaga P, Hincu M, et al. Embryonal (botryoides) rhabdomyosarcoma of the uterus harboring a primitive neuroectodermal tumor component. Int J Gynecol Pathol. 2012;31:387–389.
Cate F, Bridge JA, Crispens MA, et al. Composite uterine neoplasm with embryonal rhabdomyosarcoma and primitive neuroectodermal tumor components: rhabdomyosarcoma with divergent differentiation, variant of primitive neuroectodermal tumor, or unique entity? Hum Pathol. 2013;44:656–663.
Euscher ED, Deavers MT, Lopez-Terrada D, et al. Uterine tumors with neuroectodermal differentiation: a series of 17 cases and review of the literature. Am J Surg Pathol. 2008;32:219–228.
Chang L, Enriquez M, Lerman N, et al. High grade sarcoma, with predominant neuroectodermal and minor embryonal rhabdomyosarcomatous tumor of the uterus: a case report. Gynecol Oncol Reps. 2019;28:128–132.
Dundr P, Fischerova D, Povysil C, et al. Uterine tumors with neuroectodermal differentiation: a report of 4 cases. Pathol Oncol Res. 2010;16:601–608.
Cessna MH, Zhou H, Perkins SL, et al. Are myogenin and myoD1 expression specific for rhabdomyosarcoma? A study of 150 cases, with emphasis on spindle cell mimics. Am J Surg Pathol. 2001;25:1150–1157.
Rekhi B, Gupta C, Chinnaswamy G, et al. Clinicopathologic features of 300 rhabdomyosarcomas with emphasis upon differential expression of skeletal muscle specific markers in the various subtypes: a single institutional experience. Ann Diagn Pathol. 2018;36:50–60.
de Kock L, Rivera B, Revil T, et al. Sequencing of DICER1 in sarcomas identifies biallelic somatic DICER1 mutations in an adult-onset embryonal rhabdomyosarcoma. Br J Cancer. 2017;116:1621–1626.
Apellaniz-Ruiz M, McCluggage WG, Foulkes WD. DICER1-associated embryonal rhabdomyosarcoma and adenosarcoma of the gynecologic tract: pathology, molecular genetics, and indications for molecular testing. Genes Chromosomes Cancer. 2021;60:217–233.
McCluggage WG, Foulkes WD. DICER1-associated sarcomas: towards a unified nomenclature. Mod Pathol. 2021;34:1226–1228.
Joshi D, Anderson JR, Paidas C, et al. Age is an independent prognostic factor in rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children’s Oncology Group. Pediatr Blood Cancer. 2004;42:64–73.
Qualman S, Lynch J, Bridge J, et al. Prevalence and clinical impact of anaplasia in childhood rhabdomyosarcoma: a report from the soft tissue sarcoma committee for the children’s oncology group. Cancer. 2008;113:3242–3247.
Zhang L, Ye H, Jin Y, et al. Somatic DICER1 mutations in a pubertal girl with cervical embryonal rhabdomyosarcoma and papillary thyroid adenoma. J Pediatr Adolesc Gynecol. 2020;33:742–744.